A F Peery1, N J Shaheen, E S Dellon. 1. Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, 27599-7080, USA.
Abstract
BACKGROUND: Although consensus guidelines for eosinophilic oesophagitis have been published, it remains unclear whether gastroenterologists follow these recommendations. AIM: To assess academic and community practice patterns for the evaluation and treatment of eosinophilic oesophagitis and to compare these practices with current guidelines. METHODS: This was a prospective study of academic and community gastroenterologists using a self-administered online survey. RESULTS: A total of 60% (34 of 57) of academic and 29% (38 of 133) of community gastroenterologists completed the survey. Only 24% of academic and 3% of community gastroenterologists follow consensus guidelines to diagnose eosinophilic oesophagitis (P = 0.007). A proton pump inhibitor trial or negative pH study prior to diagnosis was required by just 25% of all gastroenterologists. A majority (60%) do not use the recommended threshold of 15 eosinophils per high powered field to diagnosis eosinophilic oesophagitis. Half (51%) mistakenly require a positive endoscopic finding. For first-line treatment, about half of the gastroenterologists surveyed treat with a swallowed topical steroid (53% academic, 56% community; P = N.S.), consistent with the guidelines. CONCLUSIONS: There is variability in practice patterns for both diagnosis and treatment of eosinophilic oesophagitis. Ongoing education and research concerning diagnosis and treatment are needed.
BACKGROUND: Although consensus guidelines for eosinophilic oesophagitis have been published, it remains unclear whether gastroenterologists follow these recommendations. AIM: To assess academic and community practice patterns for the evaluation and treatment of eosinophilic oesophagitis and to compare these practices with current guidelines. METHODS: This was a prospective study of academic and community gastroenterologists using a self-administered online survey. RESULTS: A total of 60% (34 of 57) of academic and 29% (38 of 133) of community gastroenterologists completed the survey. Only 24% of academic and 3% of community gastroenterologists follow consensus guidelines to diagnose eosinophilic oesophagitis (P = 0.007). A proton pump inhibitor trial or negative pH study prior to diagnosis was required by just 25% of all gastroenterologists. A majority (60%) do not use the recommended threshold of 15 eosinophils per high powered field to diagnosis eosinophilic oesophagitis. Half (51%) mistakenly require a positive endoscopic finding. For first-line treatment, about half of the gastroenterologists surveyed treat with a swallowed topical steroid (53% academic, 56% community; P = N.S.), consistent with the guidelines. CONCLUSIONS: There is variability in practice patterns for both diagnosis and treatment of eosinophilic oesophagitis. Ongoing education and research concerning diagnosis and treatment are needed.
Authors: Douglas G Adler; Kristen Hilden; Jason C Wills; Elizabeth Quinney; John C Fang Journal: Am J Gastroenterol Date: 2010-06 Impact factor: 10.864
Authors: Brennan M R Spiegel; Mary Farid; Eric Esrailian; Jennifer Talley; Lin Chang Journal: Am J Gastroenterol Date: 2010-03-02 Impact factor: 10.864
Authors: Evan S Dellon; Wood B Gibbs; Karen J Fritchie; Tara C Rubinas; Lindsay A Wilson; John T Woosley; Nicholas J Shaheen Journal: Clin Gastroenterol Hepatol Date: 2009-09-03 Impact factor: 11.382
Authors: Swathi Eluri; Sara R Selitsky; Irina Perjar; Johnathan Hollyfield; Renee Betancourt; Cara Randall; Spencer Rusin; John T Woosley; Nicholas J Shaheen; Evan S Dellon Journal: Clin Gastroenterol Hepatol Date: 2018-09-10 Impact factor: 11.382
Authors: Joy W Chang; Sameer D Saini; Jessica L Mellinger; Joan W Chen; Brian J Zikmund-Fisher; Joel H Rubenstein Journal: Dis Esophagus Date: 2019-06-01 Impact factor: 3.429
Authors: Dhyanesh A Patel; Tina Higginbotham; James C Slaughter; Muhammad Aslam; Elif Yuksel; David Katzka; C Prakash Gyawali; Melina Mashi; John Pandolfino; Michael F Vaezi Journal: Gastroenterology Date: 2019-01-31 Impact factor: 22.682